The feds have busted 12 shady STD treatment companies—and the Better Business Bureau might be collateral damage
The Food and Drug Administration and the Federal Trade Commission joined forces Tuesday to threaten 12 companies with legal action over the manufacture and sale of products that purport to treat sexually transmitted diseases. The FDA's webpage alone, complete with the video STD Treatments That Don't Work, will prove a devastating assault to most of these businesses. Though it lacks the authority to carry out an IRS-style raid, the FDA has been using its legal department's fearsome prose to bust bad drugs sold as supplements for decades now, and in the past few years we've seen the agency ramp up these efforts as online commerce has driven the problem to epidemic proportions.
So while I expect a steady drumbeat of deadbeat drug bashing, I was instead far more interested to discover a prominent consumer rights nonprofit linked to the mess. The Better Business Bureau lent its considerable credibility to one of the companies the Feds are slamming for endangering the country's public health. What's more, the BBB followed its normal practices and policies in doing so, the organization told me yesterday.
The BBB's involvement became apparent once I decided to take a closer look at the assortment of crappy capsules the Feds are putting on notice. I zeroed in on Medavir, produced by a central-Florida based outfit called The Arenson Group (a.k.a. TAG Health). The internet is littered with TAG's websites selling Medavir under various names. While scrolling along you'll see the usual unsubstantiated claims and endorsements from unnamed physicians that one would expect from shady operators. "Over 90% of outbreaks do not occur when you apply Medavir at first signs of outbreak," one site says. Stop the presses! For your information, that compares to about an 50 to 60 percent chance of future genital herpes outbreaks while on FDA-approved medical treatment (versus a blistering 80 to 90 percent rate without treatment) according to a 2007 meta-analysis of available trial data.
The Arenson Group preys on ashamed kids and unsophisticated adults. Your sexual partner, your doctor, and the public health department need never know!
So how's the the BBB mixed up in this? Take a look at this screen shot from one of the Medavir sites:
As shown in the above screenshot, Medavir prominently displays its BBB Accredited Business logo in the upper left hand corner of its website. Unlike the sprinkling of other certifications and logos on the site that turn out to be illegitimate, BBB's is the real deal. Until earlier today when the organization heard from me and took down their rating, consumers could click on that link to see its A+ rating from the BBB:
The BBB accredited The Arenson Group in January 2009 "based on information provided by the company and our own research," says Holly Salmons, Vice President of BBB of Central Florida.
The bottom line? The BBB is pleased to accredit questionable pill purveyors when they market their mixtures as supplements. Because The Arenson Group's website included the statement "none of these statements have been fully evaluated by the FDA" at the time they applied for accreditation (it still does), the BBB was satisfied to welcome them into its brotherhood of legitimate American businesses. In fact, Ms. Salmons says that while as of Wednesday she has frozen Arenson's status in "update" mode, the BBB will suspend or restore their accreditation only pending their response to the FDA's demands.
Arenson could potentially satisfy federal regulators by removing all medical claims from its websites and packaging and marketing Medavir in some vague manner unconnected to treating herpes sufferers. That would leave little text on their sites indeed. I find it difficult to imagine what a website attempting to sell Medavir without claiming that it treats herpes would look like (what in the world is a "herpes supplement"?), and I'd love to see the original materials the BBB reviewed in 2009.
Once BBB approved Medavir's membership, the company wasn't slated for another review for three years, giving plenty of time for its claims to become progressively more egregious without any oversight. But lack of such frequent review doesn't seem to be the crux of the problem in my own analysis. BBB protests to me that Medavir's January 2009 materials fit classification as a supplement and did not overstep bounds into FDA-regulated territory. After reviewing versions of Medavir.com from January 2009 and the oldest available version from June 2008 over at the Internet Archive, I don't buy their version of events. Take a look back, and make your own call.
The Arenson Group showed off its A+ BBB rating to its vulnerable lot of prospective consumers as an implied seal of approval. This use, even for a health care product, is routine in BBB practice. "Accredited Businesses are permitted to report their rating as long as it is accurate at all times," BBB VP Salmons tells me. Arenson had just two complaints over three years, she says, which is a low complaint volume. Another BBB policy helps explain why Medavir might have so few complaints. BBB only accepts complaints that come with real names and documentation.
People searching out genital herpes cures from the privacy of their own homes are obviously reluctant or unable to do so in the care of actual medical professionals out there in the real world. These consumers must have found some reassurance in BBB's A+ rating, which is why the Medavir site advertised it high above the fold. Medavir had a perfectly marginalized population base from which to draw its A+ record: folks too anxiety-ridden to speak up once they realized they'd been scammed; STD sufferers who didn't think admitting they have herpes to a third party was worth it when that third party took the Hippocratic Oath certainly aren't going to confide their private secrets to the BBB.
The characters behind Medavir made BBB into a Bogus Balms Bureau. To get out of this fix, BBB needs to eject itself from the field of lending credibility to unregulated drug makers entirely. This means excluding health "supplements." It's hard enough for physicians and the FDA to weigh evidence about these agents. BBB ratings are bestowed by an organization with no possible claim to competence in mediating between patients and providers in the unique health care marketplace, as the policies that led to this case prove. Moreover, BBB ratings add nothing of value to any consumer considering what pills to take for an illness. Continuing to offer accreditation to firms like The Arenson Group (aka Medavir Medical Advances) of Windmere, Florida, whether or not they barely skirt FDA enforcement does a disservice to BBB's own heritage.
Sullivan: Now we’re getting somewhere. And I’m not just referring to all of the potential wars that so many of our Game of Thrones characters are trying to either stave off or set aflame. We’ll get to those in a moment. No, I’m talking about the long-simmering question that should be on every fan’s mind, the one that showrunners David Benioff and D.B. Weiss had to answer before George R. R. Martin would hand over his series so they could bring it to television
Mary Hamm was in pain, though it was hard to tell. She bustled around the Starbucks, pouring drinks, restocking pastries, and greeting customers with an unshakable gaze perfected during 25 years of working in hospitality. Her smile said, How can I help you? Her eyes said, I know you’re going to order a caramel Frappuccino, so let’s do this.
Occupying prime space in a Fredericksburg, Virginia, strip mall, beside a Dixie Bones BBQ Post, this Starbucks pulls in about $40,000 a week. Hamm, 49, had been managing Starbucks stores for 12 years. The problem was her feet. After two decades in the food-service business, they had started to wear out. She had two metal plates in the right one, installed over the course of five surgeries. Now her left foot needed surgery too. She doesn’t like to complain, but when I asked her how often she was in pain, she smiled and said quietly, “All the time.”
Every week for the seventh and final season of AMC's hit period-drama Mad Men, Sophie Gilbert, David Sims, and Lenika Cruz will discuss the possible fates facing Don Draper and those in his orbit.
Sims: At the end of a rather spellbindingly strange episode of Mad Men, Don Draper drove off into the American unknown (well, St. Paul), having picked up a hitchhiker, in search of … it’s hard to know what, exactly. It was a powerful image, but wherever Don is going, it might be one of the show’s least interesting story threads as it approaches its conclusion. Don’s listlessness has been pointing toward this hobo journey for months now, but “Lost Horizon” wrung far more fascinating material from Joan and Peggy’s transitions to McCann Erickson. Perhaps we won’t even see Don in next week’s penultimate episode. Would that be so bad?
Journalism is, at its core, a public service. This is why several days ago the reporters at Action 7 News in Albuquerque, New Mexico, decided to investigate just what, exactly, teems within the beards of the polity. They swabbed the whiskers of a handful of local men and took the results to Quest Diagnostics.
The results were the kind that medical labs don't leave on your answering machine:
Several of the beards that were tested contained a lot of normal bacteria, but some were comparable to toilets.
“Those are the types of things you'd find in (fecal matter),” Golobic said, referring to the tests.
Even though some of the bacteria won’t lead to illness, Golobic said it’s still a little concerning.
LOS ANGELES—Over the weekend, TheNew York Times published an amusing article about New Yorkers discovering Los Angeles anew. It seems that for a long time they harbored a lot of facile prejudices about us but have lately realized that L.A. is delightful. For some, this apparently began while they were looking at Instagram. "Last fall," the article begins, "Christina Turner, a fashion stylist in Brooklyn, was dreading another New York winter in her cramped, lightless Greenpoint, Brooklyn, apartment while gazing longingly at the succulent gardens and festive backyard dinner parties posted on social media by her friends in Los Angeles."
So she moved here. I only wish that I could've gotten word to her sooner. I've always known that New Yorkers are inwardly focused. When there's a municipal election there they don't even realize we're not all picking a mayor of America together. But I would've sworn that everyone already knew about our good weather.
Where did it come from, and what are its intentions? The simplicity of these questions can be deceiving, and few Western leaders seem to know the answers. In December, The New York Times published confidential comments by Major General Michael K. Nagata, the Special Operations commander for the United States in the Middle East, admitting that he had hardly begun figuring out the Islamic State’s appeal. “We have not defeated the idea,” he said. “We do not even understand the idea.” In the past year, President Obama has referred to the Islamic State, variously, as “not Islamic” and as al-Qaeda’s “jayvee team,” statements that reflected confusion about the group, and may have contributed to significant strategic errors.
Ben Carson is one of the nation's most famous neurosurgeons. He's never run for office.
Carly Fiorina was once the CEO of Hewlett-Packard, and she ran for office once—in 2010, in a Republican wave year, when she was trounced by Democratic Senator Barbara Boxer.
Now both of them are running for the highest office in the land, the leadership of the free world. It takes an impressive amount of confidence and a certain amount of detachment from reality for even the most seasoned politicians to undertake presidential campaigns, but that's especially true of long-shot candidates like Carson and Fiorina, whose odds of becoming president are practically nil.
Both of them are trying to turn that very distance from the establishment into a rationale for their candidacies. "I'm not a politician," Carson said at his launch event in Detroit on Monday. "I don't want to be a politician because politicians do what is politically expedient. I want to do what's right." And Fiorina, in her announcement video, said: "Our founders never intended for there to be a professional political class."
The question that most people ask themselves as they walk into their boss's office to negotiate their salaries is likely some variant of "What am I going to say?" But according to hostage negotiator Chris Voss, that might be the least important thing to keep in mind when negotiating.
Voss, now an adjunct professor at Georgetown University's McDonough School of Business, spent 24 years at the FBI. It was as an FBI agent that he started to get interested in hostage negotiations. At the time, a supervisor told him to start by volunteering at a suicide hotline to gain the set of listening abilities that a hostage negotiator needs. By 1992, he was training at the FBI's school for negotiators, and from 2004 to 2007, he was the FBI's lead international hostage negotiator. After retirement, Voss founded The Black Swan Group to bring negotiation know-how to the business world.
On Sunday night, two gunmen opened fire outside a complex in Garland, Texas, that was hosting a contest featuring cartoons of the Prophet Muhammad. Both gunmen were killed and one security officer was injured in the shootout.
What We Know About the Shooting
Sunday's shooting took place outside the Muhammad Art Exhibit and Cartoon Contest, which was being held in Garland, a city just northeast of Dallas. The contest, which offered a $10,000 prize, was hosted by the American Freedom Defense Initiative, a group widely characterized as Islamaphobic.
"As today’s Muhammad Art Exhibit event at the Curtis Culwell Center was coming to an end, two males drove up to the front of the building in a car,"officials wroteon the the city's Facebook page. "Both males were armed and began shooting at a Garland ISD security officer. The GISD security officer's injuries are not life-threatening. Garland Police officers engaged the gunmen, who were both shot and killed."
Every candidate in the 2016 race so far is an experienced politician. That changes Monday with the addition of two new candidates with little electoral experience: neurosurgeon Ben Carson and former executive Carly Fiorina. Both chose Monday to announce their presidential campaigns, and both face an uphill battle against the GOP establishment.
Carson has confirmed his run with reporters, but the big kickoff will be a rally in Detroit, his hometown, Monday afternoon. Fiorina, meanwhile, is eschewing a big launch in favor of an online rollout, and announced her campaign with a tweet early Monday morning.
The field is expected to grow again on Tuesday when Mike Huckabee—the former Arkansas governor who made a strong showing in 2008, placing third in the Republican primary—makes his decision about a run formal.